BHVN vs AGIO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BHVN Captures Institutional Edge (3โ1 Pillars ยท 4โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biohaven Ltd. (BHVN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while AGIO counters with relative strength in Valuation. Fundamentally, BHVN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus AGIO at 2.5x Forward P/E and -297.7% operating margin (+330.0% YoY). In options structure, BHVN sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro) against AGIO sits in UNCLASSIFIED (16th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BHVN | AGIO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.1B | $1.9B | Larger Scale | BHVN |
| Trailing P/E Ratio Valuation | N/M | 2.5x | Lower Multiple | AGIO |
| Forward P/E Ratio Valuation | N/M | 2.5x | Lower Multiple | AGIO |
| Revenue Growth (YoY) Growth | +0.0% | +330.0% | Higher Growth | AGIO |
| Operating Margin (TTM) Profitability | 0.0% | -297.7% | Higher Margin | BHVN |
| Net Profit Margin Profitability | 0.0% | -264.8% | Higher Margin | BHVN |
| Return on Equity (ROE) Capital Efficiency | -799.5% | -33.0% | Higher ROE | AGIO |
| 52-Week Range Position Momentum | 59% ($8โ$18) | 34% ($22โ$46) | Stronger Trend | BHVN |
| Beta / 30D Volatility Risk Regime | 1.41ฮฒ ยท 111% Vol | 1.12ฮฒ ยท 85% Vol | Lower Realized Risk | AGIO |
| Unified Institutional Score Composite Signal | 42.1 / 100 (HOLD) | 55.9 / 100 (HOLD) | Higher Composite | AGIO |